The next board meeting for Adaptimmune Therapeutics Plc - ADR is on 13 Nov 2025 for the purpose of Adaptimmune Therapeutics PLC Third Quarter Earnings Results for 2025See details
Adaptimmune Therapeutics Plc - ADR has a share price target of US$ 1, revenue growth forecast of -77.3%, and profit growth estimate of -31.3% for FY25, based on top 3 analyst calls.